ATE237365T1 - Technetium-99-markierte peptide zur visualisierung vom entzuendungen - Google Patents

Technetium-99-markierte peptide zur visualisierung vom entzuendungen

Info

Publication number
ATE237365T1
ATE237365T1 AT93911556T AT93911556T ATE237365T1 AT E237365 T1 ATE237365 T1 AT E237365T1 AT 93911556 T AT93911556 T AT 93911556T AT 93911556 T AT93911556 T AT 93911556T AT E237365 T1 ATE237365 T1 AT E237365T1
Authority
AT
Austria
Prior art keywords
technetium
peptides
inflammation
visualizing
labeled peptides
Prior art date
Application number
AT93911556T
Other languages
English (en)
Inventor
Richard T Dean
Robert S Lees
Scott Buttram
John Lister-James
Original Assignee
Diatide Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diatide Inc filed Critical Diatide Inc
Application granted granted Critical
Publication of ATE237365T1 publication Critical patent/ATE237365T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT93911556T 1992-03-13 1993-03-12 Technetium-99-markierte peptide zur visualisierung vom entzuendungen ATE237365T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85107492A 1992-03-13 1992-03-13
PCT/US1993/002320 WO1993017719A1 (en) 1992-03-13 1993-03-12 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION

Publications (1)

Publication Number Publication Date
ATE237365T1 true ATE237365T1 (de) 2003-05-15

Family

ID=25309908

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93911556T ATE237365T1 (de) 1992-03-13 1993-03-12 Technetium-99-markierte peptide zur visualisierung vom entzuendungen

Country Status (11)

Country Link
US (3) US6017510A (de)
EP (1) EP0630265B1 (de)
JP (1) JPH07504902A (de)
AT (1) ATE237365T1 (de)
AU (1) AU683015B2 (de)
CA (1) CA2131816C (de)
DE (1) DE69332879T2 (de)
DK (1) DK0630265T3 (de)
ES (1) ES2194846T3 (de)
PT (1) PT630265E (de)
WO (1) WO1993017719A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792444A (en) * 1989-05-09 1998-08-11 The General Hospital Corporation Labeled chemotactic peptides to image focal sites of infection or inflammation
US5700444A (en) * 1992-02-20 1997-12-23 Rhomed Incorporated Chemotactic peptide pharmaceutical applications
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US5997844A (en) * 1991-02-08 1999-12-07 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US6019958A (en) * 1991-02-08 2000-02-01 Diatide, Inc. Technetium-99m labeled peptides for imaging inflammation
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US7238340B1 (en) * 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5552525A (en) * 1991-02-08 1996-09-03 Diatech Inc. Technetium-99m labeled peptides for imaging inflammation
JPH07504902A (ja) * 1992-03-13 1995-06-01 ダイアタイド・インコーポレイテッド 炎症造影用のテクネチウム−９９ｍ標識ペプチド
US5989519A (en) * 1992-03-13 1999-11-23 Diatide, Inc. Technetium-99m labeled peptides for imaging inflammation
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
DE69426035T2 (de) * 1993-07-28 2001-05-17 Diatide, Inc. Radiomarkierte glukane
US5480970A (en) * 1993-12-22 1996-01-02 Resolution Pharmaceuticals Metal chelators
CA2179990A1 (en) * 1994-01-12 1995-07-20 Gary Robert Bower Biological targeting agents
US5569745A (en) * 1994-02-25 1996-10-29 Resolution Pharmaceuticals Inc. Peptide-Chelator conjugates
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
ZA955642B (en) * 1994-07-07 1997-05-06 Ortho Pharma Corp Lyophilized imaging agent formulation
US5891418A (en) * 1995-06-07 1999-04-06 Rhomed Incorporated Peptide-metal ion pharmaceutical constructs and applications
US6331285B1 (en) 1996-06-05 2001-12-18 Palatin Technologies, Inc. Structurally determined cyclic metallo-constructs and applications
CA2362860A1 (en) * 1999-02-17 2000-08-24 Bracco International B.V. Immobilized labeling compounds and methods
AU781249B2 (en) * 1999-06-30 2005-05-12 Regents Of The University Of California, The Diagnostic test for thrombotic or thromboembolic disease
US6673561B1 (en) 1999-06-30 2004-01-06 Regents Of The University Of California Diagnostic test for thrombotic or thromboembolic disease
US6254852B1 (en) 1999-07-16 2001-07-03 Dupont Pharmaceuticals Company Porous inorganic targeted ultrasound contrast agents
US6685914B1 (en) 1999-09-13 2004-02-03 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
US6782289B1 (en) 1999-10-08 2004-08-24 The Board Of Trustees Of The Leland Stanford Junior University Methods and apparatus for characterizing lesions in blood vessels and other body lumens
JP2003530544A (ja) * 2000-01-04 2003-10-14 アイメトリクス インコーポレイティッド 血管内画像処理検出器
US7385025B2 (en) 2000-12-19 2008-06-10 Palatin Technologies, Inc. Metallopeptide compounds
TWI284539B (en) 2001-07-30 2007-08-01 Epix Pharm Inc A method for making a magnetic resonance (MR) imaging agent, a MR imaging contrast agent, a method for altering stability of a peptide and a modified peptide
US20030152513A1 (en) * 2001-09-06 2003-08-14 Imetrix, Inc. Intravascular delivery of therapeutic and imaging agents to stressed and apoptotic cells using annexin V as a targeting vector
EP1437145A1 (de) * 2003-01-07 2004-07-14 Schering AG Verbesserte szintigraphische bildgebende Mittel zur Darstellung von Infektionen und Entzündungen
US7319149B2 (en) * 2003-06-13 2008-01-15 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
US7317104B2 (en) 2003-06-13 2008-01-08 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
US7651506B2 (en) * 2003-10-02 2010-01-26 University Of Florida Research Foundation, Inc. Frameless stereotactic guidance of medical procedures
WO2006047290A2 (en) 2004-10-21 2006-05-04 Bayer Healthcare Llc Method of determining the concentration of an analyte in a body fluid and system therefor
US7874975B2 (en) * 2005-07-20 2011-01-25 Clear Vascular, Inc. Methods and compositions for treating luminal inflammatory disease
US9623129B2 (en) * 2005-09-26 2017-04-18 Snip Holdings, Inc. Methods and therapies for treating inflammatory conditions with exposed collagen
DE102013113156A1 (de) 2013-11-28 2015-05-28 Freie Universität Berlin Verbindung und Verfahren zur selektiven Radiomarkierung von Polypeptiden mittels Festphasensynthese
ES2894201B2 (es) * 2020-08-05 2022-09-29 Fundacion Para La Investig Biomedica Del Hospital Gregorio Maranon Compuestos radioactivos basados en proteinas selectivas de bacterias para la deteccion no invasiva de focos infecciosos
CA3247684A1 (en) * 2022-01-12 2023-07-20 Cumberland Emerging Technologies, Inc. DETECTION AND LOCALIZATION OF INTERNAL BLEEDING

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615876A (en) * 1983-04-25 1986-10-07 Curators Of The University Of Missouri Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments
US4889524A (en) * 1987-09-04 1989-12-26 Haemonetics Corporation Portable centrifuge apparatus
AU3778989A (en) * 1988-04-29 1989-11-29 Mallinckrodt, Inc. Diaminedithiol chelating agents for radiopharmaceuticals
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
US5376356A (en) * 1989-03-14 1994-12-27 Neorx Corporation Imaging tissue sites of inflammation
NZ314680A (en) * 1989-05-09 2000-08-25 Ortho Pharma Corp Treating localised infection or inflammation with a therapeutically conjugated chemotactic peptide
DE69023394T2 (de) * 1989-06-16 1996-07-04 Merck Frosst Canada Inc Chelat-Derivate von atrialnatriurethischem Faktor (ANF).
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5261051A (en) * 1989-08-14 1993-11-09 Microsoft Corporation Method and system for open file caching in a networked computer system
US5190920A (en) * 1990-09-24 1993-03-02 W. R. Grace & Co.-Conn. Method for using synthetic analogs of thrombospondin for inhibiting metastasis activity
AU663291B2 (en) * 1990-05-03 1995-10-05 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
US5277892A (en) * 1990-08-08 1994-01-11 Rhomed Incorporated In vivo lymphocyte tagging
US5997844A (en) * 1991-02-08 1999-12-07 Diatide, Inc. Technetium-99m labeled peptides for imaging
EP0570493B1 (de) * 1991-02-08 2000-01-05 Diatide, Inc. Technetium-99m markierte Polypeptide zur Bildformung
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US5552525A (en) * 1991-02-08 1996-09-03 Diatech Inc. Technetium-99m labeled peptides for imaging inflammation
JPH07504902A (ja) * 1992-03-13 1995-06-01 ダイアタイド・インコーポレイテッド 炎症造影用のテクネチウム−９９ｍ標識ペプチド
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
ATE196094T1 (de) * 1992-05-21 2000-09-15 Diatide Inc Technetium-99m markierte peptide zur bilderzeugung von thrombus
EP0649857B1 (de) * 1993-10-22 1999-01-20 NIHON MEDI-PHYSICS Co., Ltd. Peptide mit Affinität für Entzündungen und deren radiomarkierte, diagnostische Zusammensetzungen
US5552278A (en) * 1994-04-04 1996-09-03 Spectragen, Inc. DNA sequencing by stepwise ligation and cleavage

Also Published As

Publication number Publication date
WO1993017719A1 (en) 1993-09-16
US5807538A (en) 1998-09-15
DK0630265T3 (da) 2003-06-30
JPH07504902A (ja) 1995-06-01
DE69332879D1 (de) 2003-05-22
DE69332879T2 (de) 2004-02-19
EP0630265B1 (de) 2003-04-16
PT630265E (pt) 2003-07-31
US6017510A (en) 2000-01-25
EP0630265A1 (de) 1994-12-28
CA2131816C (en) 2001-08-28
ES2194846T3 (es) 2003-12-01
CA2131816A1 (en) 1993-09-14
AU683015B2 (en) 1997-10-30
AU4043893A (en) 1993-10-05
US5711931A (en) 1998-01-27

Similar Documents

Publication Publication Date Title
ATE237365T1 (de) Technetium-99-markierte peptide zur visualisierung vom entzuendungen
DE69434729D1 (de) TECHNETIUM-99m MARKIERTE PEPTIDE ZUR DIAGNOSTISCHEN BILDERZEUGUNG VON ENTZÜNDUNGEN
ATE184203T1 (de) Technetium-99m-markierte peptide zur bilderzeugung
DK0644778T3 (da) Technetium-99-mærkede peptider til imagografi
DK0762901T3 (da) Technetium-99m-mærkede peptider til imagografi
DK0649434T3 (da) Radioaktivt mærkede somatostatin-afledte peptider til billeddannende og terapeutiske anvendelser
DK0720621T3 (da) Radiomærkede somatostation-afledte peptider til billeddannende og terapeutiske anvendelser
ATE237637T1 (de) Somatostatin derivate und deren radiomarkierte produkte
ATE213168T1 (de) Technetium - 99m markierte peptide zur bildformung
DK0570493T3 (da) Technetium-99m-mærkede polypeptider til billeddannelse.
MX9707426A (es) Peptidos marcados radioactivamente para diagnostico y terapia.
DE69329382D1 (de) Technetium-99m markierte peptide zur bilderzeugung von thrombus
ATE182795T1 (de) Technetium-99m markierte peptide zur bilderzeugung der entzuendung
CA2347670A1 (en) Radiolabeled somatostatin-derived peptides for imaging

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0630265

Country of ref document: EP

REN Ceased due to non-payment of the annual fee